Once a doctor mentions finasteride, a lot of men go straight to Google to ask if there’s a “natural version” that does the same thing without the prescription.
Saw palmetto usually comes up first. It’s marketed as working through a similar pathway, and it’s sold over the counter. But similar mechanism doesn’t mean similar results.
Here’s an honest, evidence-based comparison of what each option actually does, how strong the data is behind each, and where the real trade-offs are.
How Each One Is Supposed to Work
Both target the same hormone pathway, which is exactly why they get compared so often.
Finasteride is a 5-alpha reductase inhibitor. It blocks the enzyme that converts testosterone into dihydrotestosterone (DHT), the hormone that drives prostate tissue growth. This is a well-characterized, potent, and predictable mechanism — it’s a prescription drug specifically because it reliably suppresses DHT in a way supplements don’t.
Saw palmetto is thought to inhibit the same enzyme, but far more mildly and less predictably, alongside some anti-inflammatory activity. It’s the “same idea, weaker tool” comparison that shows up constantly in men’s health forums, and the research generally backs that framing up.
What the Evidence Shows for Each
Finasteride’s trial record is large and consistent. The PLESS trial, a four-year, placebo-controlled study of over 3,000 men, found finasteride reduced the combined risk of acute urinary retention and BPH-related surgery by roughly half, alongside durable improvements in symptom scores and a sustained reduction in prostate volume. An earlier landmark trial published in the New England Journal of Medicine found prostate volume dropped by about 19% at 12 months on the standard 5 mg dose, with roughly half of men seeing a 20%+ reduction in prostate size.
Saw palmetto’s trial record is large but disappointing. As we cover in our deep dive into saw palmetto’s BPH research, the most recent and rigorous Cochrane review — 27 trials, over 4,600 men — found saw palmetto performed close to placebo on symptom scores, urine flow, and prostate volume.
Why older sources sometimes say otherwise. This is a genuinely common point of confusion. An earlier (2002) Cochrane review had found saw palmetto’s symptom improvement comparable to finasteride’s. That conclusion gets repeated on a lot of supplement and health sites that haven’t updated their sources. But Cochrane’s own 2023 update superseded that finding — the newer, larger, better-designed trial pool did not replicate it. When evidence updates, the newer data should carry more weight.
Effectiveness Comparison
| Finasteride | Saw Palmetto | |
|---|---|---|
| Reduces prostate volume | Yes — ~18–19% at 12 months | No significant effect vs. placebo |
| Improves symptom scores | Yes, consistently across large trials | Little to no difference vs. placebo in current Cochrane data |
| Lowers risk of urinary retention/surgery | Yes — ~50% relative risk reduction (PLESS) | Not established |
| Effect on PSA | Lowers PSA by ~50% | No meaningful effect |
| Onset of benefit | Volume changes measurable by 3 months; full effect over 6–12 months | Not established, given inconsistent efficacy |
Side Effect Profiles Are Where They Really Diverge
This is the part that pushes a lot of men toward saw palmetto in the first place, and it’s a legitimate consideration even given the effectiveness gap above.
Finasteride’s side effects are well-documented and can be significant for some men: reduced libido, erectile dysfunction, and decreased ejaculate volume are the most common. A smaller subset of men report symptoms — sexual, physical, or psychological — that persist after stopping the drug, a condition referred to as post-finasteride syndrome. It’s considered uncommon overall, but it’s a real, FDA-acknowledged risk that’s part of an informed decision.
Saw palmetto’s side effect profile is mild by comparison — occasional stomach upset, headache, or dizziness in a small percentage of users, with no established link to sexual side effects. This favorable tolerability is well established even though its effectiveness data isn’t.
The PSA Testing Difference Matters
This is a clinically important, often-overlooked distinction. Finasteride cuts PSA levels roughly in half, which means a doctor has to account for that when interpreting a PSA test for prostate cancer screening — missing this adjustment could theoretically mask a rising PSA that would otherwise prompt further workup.
Saw palmetto does not meaningfully affect PSA, so it doesn’t complicate cancer screening the same way. For men who want to keep PSA monitoring straightforward, this is a genuine point in saw palmetto’s favor, separate from the question of whether it relieves symptoms.
Who Might Choose Which
Finasteride tends to make sense for:
- Men with a significantly enlarged prostate and moderate-to-severe symptoms, where the goal is reducing the risk of retention or surgery, not just symptom comfort
- Men who’ve discussed the sexual side effect risk with a doctor and are comfortable with the trade-off for a stronger, better-established effect
Saw palmetto tends to make sense for:
- Men with mild symptoms who want to try a low-risk, well-tolerated option first
- Men who are highly averse to sexual side effects and are willing to accept a smaller, less certain benefit
- Men who want to avoid any complication with PSA-based cancer screening while still trying something
Neither is the right unsupervised choice for:
- Men with sudden urinary retention, blood in the urine, or symptoms suggestive of infection — these need prompt medical evaluation, not a supplement or a prescription refill
FAQs
Is saw palmetto a safe substitute for finasteride?
It’s safe in the sense that it has few side effects, but “safe” isn’t the same as “effective.” Current trial evidence doesn’t support saw palmetto as a reliable substitute for finasteride’s demonstrated effects on prostate volume and urinary retention risk.
Can I take saw palmetto and finasteride together?
This combination isn’t well studied. Since both act on a similar pathway, combining them without medical supervision isn’t recommended — talk to a doctor before adding a supplement to a prescription regimen.
Does saw palmetto cause the same sexual side effects as finasteride?
No. Saw palmetto has not been linked to the sexual side effects associated with finasteride in clinical trials, which is part of why it remains popular despite the weaker effectiveness data.
Why do some websites say saw palmetto works as well as finasteride?
Many are citing an older (2002) Cochrane review that has since been superseded. The more recent 2023 Cochrane update, based on more and larger trials, did not find saw palmetto outperforming placebo.
Does finasteride shrink the prostate permanently, or does it come back?
Prostate volume reduction is maintained only while taking the drug consistently — stopping finasteride generally allows the prostate to resume its natural growth pattern over time.
Should I ask my doctor about finasteride or try saw palmetto first?
That depends on symptom severity. Mild symptoms with a normal prostate exam may reasonably start with watchful waiting or a supplement trial; moderate-to-severe symptoms or a significantly enlarged prostate usually warrant a direct conversation about prescription options.
Final Thoughts
Finasteride has the stronger, more consistent evidence base — reduced prostate volume, lower symptom scores, and a meaningfully lower risk of urinary retention and BPH surgery in large trials. That effectiveness comes with a real, if uncommon, risk of persistent sexual side effects.
Saw palmetto is much better tolerated but, based on the most rigorous current evidence, doesn’t reliably outperform placebo. It may still appeal to men with mild symptoms who want the lowest-risk option to try first.
If you’re comparing specific saw palmetto and pumpkin seed oil products rather than the prescription route, our roundup of pumpkin seed oil with saw palmetto supplements is a good next stop, and our pumpkin seed oil research breakdown covers a supplement option with a somewhat more encouraging trial record.
Doctor’s Note: This comparison is for general education, not a recommendation to start or stop either option. Prostate size, symptom severity, PSA trends, and personal risk tolerance for sexual side effects should all factor into that decision with a urologist.
